Member of the Latinoamerican Board of Eli Lilly and Sanofi Aventis Member of the National Board of the following laboratories: Novo Nordisk, Novartis, GlaxoSmithKlein Sanofi, Aventis, Boheringer Ingelheim, Bristol Myers, Astra Zeneca Main investigator of Protocols from: Eli Lilly, Novo Nordisk, Novartis, GlaxoSmithKlein, Takeda, PPDF, Pfizer, Merck Sharp Dome, Amgen, Roche, Minimed, Quintiles Speakers of the former laboratories
Its not a short-term fix, its part of a long-term, sustainable plan." Key Insight: Addressing misconceptions helps patients feel informed, reduces uncertainty, and encourages engagement and adherence
K.RenaudJ.KagaleS.DhaubhadelS
In fact, metformin shows such great promise as an anti-aging drug (Martin-Montalvo 2013